IHH Healthcare Berhad provides healthcare services primarily in Asia, Central and Eastern Europe, the Middle East, and North Africa. The company operates through four segments: Parkway Pantai, Acibadem, Parkway Life REIT, and IMU Health. It provides primary care services, including treatment of basic illnesses, routine check-ups, vaccination, and dental services. The company also offers secondary services, such as specialist consultation, local surgeries, emergency care, laboratory services and diagnostics, and acute treatment; and tertiary care services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services, as well as operates quaternary h...
Pantai Hospital Kuala Lumpur
Level 11, Block A
8 Jalan Bukit Pantai
Kuala Lumpur, 59100
IHH Healthcare Berhad Proposes First and Final Single Tier Cash Dividend for the Financial Year Ended December 31, 2015, Payable on July 18, 2016
Jun 30 16
IHH Healthcare Berhad proposed a first and final single tier cash dividend of 3 sen per ordinary share of MYR 1.00 each for the financial year ended 31 December 2015. EX-date is 28 June 2016 and entitlement date is 30 June 2016. Payment date is 18 July 2016.
IHH Healthcare To Acquire Vikram Hospital
Jun 8 16
IHH Healthcare Berhad (KLSE:IHH) is planning to acquire Vikram Hospital Private Limited. The company is close to finalizing the INR 6 billion deal to acquire Vikram Hospital, people familiar with the development said. The deal is expected to close by July, 2016.
IHH Healthcare Berhad Reports Consolidated Unaudited Earnings Results for the First Quarter Ended March 31, 2016; Reports Write-Off of Property, Plant and Equipment for the First Quarter Ended March 31, 2016
May 26 16
IHH Healthcare Berhad reported consolidated unaudited earnings results for the first quarter ended March 31, 2016. For the quarter, the company reported revenue of MYR 2,475,355,000 compared with MYR 2,002,971,000 for the same period last year. Profit before tax was MYR 355,300,000 compared with MYR 232,937,000 for the same period last year. Profit attributable to ordinary equity holders of the parent was MYR 235,478,000 or 2.86 sen per diluted share compared with MYR 171,482,000 or 2.09 sen per diluted share for the same period last year. Net cash generated from operating activities was MYR 383,978,000 compared with MYR 453,001,000 for the same period last year. Purchase of property, plant and equipment was MYR 325,844,000 compared with MYR 312,139,000 for the same period last year. The Group achieved 24% and 22% growth for revenue and EBITDA respectively. The increase in First Quarter 2016 revenue was attributed to organic growth of existing operations and the commencement of operations of Gleneagles Kota Kinabalu Hospital (opened in May 2015), Acibadem Taksim Hospital (opened in October 2015) and Gleneagles Medini Hospital (opened in November 2015). EBITDA was MYR 616,981,000 compared to MYR 614,333,000 a year ago.
For the quarter, the company reported write-off of property, plant and equipment was MYR 73,000 compared to MYR 545,000 a year ago.